Bernard Gallez Selected Research

syrosingopine

6/2022

Evaluation of Syrosingopine, an MCT Inhibitor, as Potential Modulator of Tumor Metabolism and Extracellular Acidification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernard Gallez Research Topics

Disease

114	Neoplasms (Cancer) 06/2022 - 06/2002
28	Hypoxia (Hypoxemia) 12/2020 - 01/2003
12	Melanoma (Melanoma, Malignant) 03/2022 - 03/2008
7	Breast Neoplasms (Breast Cancer) 06/2022 - 03/2015
7	Fibrosarcoma 05/2013 - 06/2002
5	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2018
5	Ischemia 04/2019 - 08/2004
5	Wounds and Injuries (Trauma) 01/2018 - 11/2007
4	Neoplasm Metastasis (Metastasis) 03/2022 - 07/2011
4	Rhabdomyosarcoma 01/2019 - 02/2015
4	Experimental Melanoma 05/2012 - 11/2007
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2021 - 02/2018
3	Glioma (Gliomas) 01/2019 - 07/2009
3	Hyperthyroidism 06/2011 - 10/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2022 - 12/2008
2	Obesity 12/2020 - 01/2020
2	Brain Neoplasms (Brain Tumor) 01/2020 - 02/2016
2	Necrosis 04/2016 - 03/2012
2	Skin Neoplasms (Skin Cancer) 06/2013 - 03/2012
2	Inflammation (Inflammations) 07/2009 - 11/2005
2	Hypercapnia 11/2006 - 02/2006

Drug/Important Bio-Agent (IBA)

41	Oxygen (Dioxygen)IBA 03/2022 - 06/2002
19	carbogenIBA 04/2019 - 01/2003
10	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013 - 06/2002
9	Pharmaceutical PreparationsIBA 03/2022 - 12/2002
9	LipidsIBA 12/2020 - 03/2007
9	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2006
8	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 12/2008
7	Lactic Acid (Lactate)FDA LinkGeneric 06/2022 - 12/2008
7	Paclitaxel (Taxol)FDA LinkGeneric 10/2019 - 01/2012
6	ferric oxide (iron oxide)IBA 06/2019 - 07/2009
6	Melanins (Melanin)IBA 04/2019 - 03/2008
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2015 - 11/2009
4	Proteins (Proteins, Gene)FDA Link 03/2014 - 03/2007
4	A-factor (Streptomyces)IBA 10/2012 - 06/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2010 - 02/2006
4	Insulin (Novolin)FDA Link 10/2006 - 06/2002
3	VemurafenibIBA 03/2022 - 03/2018
3	Pyruvic Acid (Pyruvate)IBA 03/2022 - 12/2016
3	Superoxides (Superoxide)IBA 03/2022 - 08/2014
3	Charcoal (Charbon)IBA 01/2021 - 04/2003
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2007
3	Hemoglobins (Hemoglobin)IBA 01/2020 - 09/2011
3	HydrogelsIBA 10/2019 - 06/2017
3	IntegrinsIBA 06/2019 - 11/2014
3	GoldIBA 01/2019 - 09/2013
3	Contrast MediaIBA 01/2019 - 11/2006
3	Radiation-Sensitizing AgentsIBA 01/2019 - 03/2003
3	Choline (Choline Chloride)IBA 03/2018 - 05/2013
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2016 - 12/2003
3	Sorafenib (BAY 43-9006)FDA Link 04/2016 - 10/2012
3	EnzymesIBA 01/2016 - 03/2010
3	LuciferasesIBA 03/2015 - 07/2011
3	Thyroxine (Levothyroxine)FDA LinkGeneric 06/2011 - 10/2007
3	NitritesIBA 04/2010 - 05/2008
3	Nitric Oxide Synthase (NO Synthase)IBA 07/2009 - 06/2002
3	Thalidomide (Thalomid)FDA Link 01/2008 - 01/2005
2	trametinibIBA 03/2022 - 03/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2022 - 03/2018
2	AntioxidantsIBA 03/2022 - 10/2011
2	Monocarboxylic Acid TransportersIBA 08/2021 - 01/2012
2	Drug CombinationsIBA 10/2019 - 01/2016
2	Protons (Proton)IBA 01/2019 - 11/2014
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 09/2018 - 01/2018
2	lithium phthalocyanineIBA 01/2018 - 01/2015
2	CytokinesIBA 01/2018 - 03/2014
2	AntibodiesIBA 01/2018 - 01/2016
2	fluoroazomycin arabinosideIBA 12/2017 - 10/2012
2	NitroimidazolesIBA 01/2017 - 10/2012
2	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 12/2016 - 11/2010
2	Small Interfering RNA (siRNA)IBA 04/2016 - 03/2010
2	fosbretabulin (combretastatin A4)IBA 02/2016 - 11/2014
2	Gemcitabine FDA Link 01/2016 - 01/2008
2	EndoglinIBA 01/2016 - 09/2014
2	FluorineIBA 01/2016 - 01/2008
2	MicellesIBA 02/2015 - 01/2012
2	palmidrolIBA 03/2012 - 01/2011
2	EndocannabinoidsIBA 03/2012 - 01/2011
2	CatalaseIBA 10/2011 - 08/2010
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 03/2010 - 02/2008
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2010 - 01/2007
2	CaveolinsIBA 07/2009 - 11/2007
2	FluorocarbonsIBA 03/2009 - 08/2008
2	Anesthetics (Anesthetic Agents)IBA 03/2009 - 09/2004
2	arginine methyl esterIBA 01/2009 - 06/2002
2	Biological ProductsIBA 01/2009 - 04/2008
2	incobotulinumtoxinA FDA Link 01/2008 - 02/2006
2	Type A Botulinum Toxins (Botox)FDA Link 01/2008 - 02/2006
2	Botulinum Toxins (Botulinum Toxin)IBA 02/2007 - 02/2006
2	Angiogenesis InhibitorsIBA 11/2006 - 01/2005
2	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 09/2006 - 09/2005
2	Endothelin-1 (Endothelin 1)IBA 06/2006 - 05/2004
2	Diclofenac (SR 38)FDA LinkGeneric 11/2005 - 09/2005
2	FlunarizineIBA 08/2004 - 06/2003

Therapy/Procedure

29	Radiotherapy 01/2019 - 06/2002
28	Therapeutics 03/2022 - 10/2006
12	Drug Therapy (Chemotherapy) 12/2017 - 01/2003
6	Aftercare (After-Treatment) 02/2015 - 06/2003
6	Lasers (Laser) 05/2013 - 06/2002
2	Injections 01/2020 - 09/2018